Related Experiment Video
Updated: Jul 13, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Lead exposure effect on angiotensin II renal vasoconstriction
Hilda Vargas Robles1, Eunice Romo, Alicia Sanchez-Mendoza
1Department of Molecular Biomedicine, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), México City, México.
Chronic lead exposure in rats increased blood pressure and vascular reactivity, suggesting lead-induced hypertension is linked to an altered nitric oxide (NO) system and oxidative stress.
Area of Science:
- Environmental Health
- Cardiovascular Physiology
- Toxicology
Background:
- Low-level chronic lead exposure is linked to hypertension and endothelial dysfunction.
- These effects may involve oxidative stress and imbalances in vascular tone regulation.
- The precise mechanisms of lead's impact on the nitric oxide (NO) system require further investigation.
Purpose of the Study:
- To investigate the effect of chronic lead exposure on angiotensin II-induced vasoconstriction in isolated perfused rat kidneys and microvessels.
- To assess the role of the NO system and oxidative stress in lead-induced hypertension.
Main Methods:
- Male Wistar rats were treated with lead acetate (100 ppm) or water for 12 weeks.
- Vascular reactivity to angiotensin II was evaluated in kidneys and microvessels, with and without N(omega)-nitro-L-arginine methyl ester (L-NAME).
- Nitrite concentration, 3-nitrotyrosine, endothelial NO synthase (eNOS) expression, and superoxide production (via dihydroethidium) were measured.
Main Results:
- Lead exposure significantly increased blood pressure, eNOS expression, oxidative stress, and vascular reactivity to angiotensin II.
- L-NAME potentiated angiotensin II response in controls but not in lead-exposed rats.
- Lead-exposed rats showed lower renal nitrite release and higher 3-nitrotyrosine levels compared to controls.
Conclusions:
- Chronic lead exposure partially causes hypertension through an altered NO system.
- Increased oxidative stress and impaired NO bioavailability contribute to lead-induced endothelial dysfunction and vasoconstriction.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Direct Renin Inhibitors
Hypertension II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Action of β1 Blockers
